^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CHO-H01

    i
    Other names: CHO-H01, CHO H01, glyco-engineered anti-CD20 antibody
    Associations

    News

    Trials
    Company:
    Cho Pharma
    Drug class:
    CD20 inhibitor
    Related drugs:
    Associations

    News

    Trials
    10ms
    A Study to Assess Safety and Efficacy of CHO-H01 in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma (clinicaltrials.gov)
    P1/2, N=11, Recruiting, Cho Pharma Inc.
    New P1/2 trial
    |
    CD20 (Membrane Spanning 4-Domains A1)
    |
    CHO-H01